Astellas Discontinues Individual HCP Funding
15 December 2020: At Astellas, our culture is rooted in openness and integrity, and we continuously work to be a trusted leader in the ever-changing healthcare environment. In step with the evolving global landscape, Astellas will no longer provide funding directly to individual healthcare professionals (HCPs) to attend congresses and conferences, including virtual attendance. This decision is part of our efforts to continue to build our reputation as an ethical company working transparently with our external stakeholders. Our consistent approach to transparency and integrity around the world is critical to our reputation and the trust we share with healthcare professionals, the patients they serve, and the broader healthcare community.
Here in Belgium and Luxembourg and around the world, Astellas remains committed to providing ongoing high-quality medical education opportunities that help ensure appropriate clinical use of our existing medications and new medical innovations, fulfil educational needs/gaps and, ultimately, improve patient care. Astellas will continue to share new scientific data and disease information in a variety of formats that support the critical role of HCPs in improving patient care, including:
- Grants for Medical Education, also known as Independent Medical Education (IME)
- Symposia, webinars, e-learnings and web-based education (disease, treatment or product focused); examples include satellite symposia during a congress, speaker programs and product theatres
- Congress summaries
- Healthcare Organization (HCO) grants for education
- Sponsorship of educational conferences
Learn more about the Astellas HCP Funding decision on our Responsible Business Activities page.